Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

A woman with severe hair loss was successfully treated with the drug adalimumab.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

A woman and her daughter had thallium poisoning from a herbal drink and rodenticide, causing hair loss and other symptoms.

Early recognition and treatment of LPP can prevent hair loss and improve quality of life.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Etanercept effectively treated a severe skin condition when other treatments failed.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Tofacitinib works better than methotrexate for severe alopecia in the short term.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Anti-CD19 therapy may help treat SLE and NMOSD.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Ixekizumab effectively treats generalized pustular psoriasis.